A simplified cost-effectiveness model to guide decision-making for shortened anti-tuberculosis treatment regimens

A. Zwerling; G. B. Gomez; J. Pennington; F. Cobelens; A. Vassall; D. W. Dowdy

doi:https://doi.org/10.5588/ijtld.15.0415

A simplified cost-effectiveness model to guide decision-making for shortened anti-tuberculosis treatment regimens

A. Zwerling, G. B. Gomez, J. Pennington, F. Cobelens, A. Vassall, D. W. Dowdy

Research output: Contribution to journal › Article › Academic › peer-review

2 Citations (Scopus)

Abstract

User-friendly models (UFMs) allow local decision makers to explore relationships and apply results from more detailed models of such outcomes as cost-effectiveness. When developing UFMs, modelers must decide which simplifications may be appropriate, enabling the UFM to retain accuracy while reducing complexity. We use the example of cost-effectiveness analysis (CEA) for novel shortened anti-tuberculosis treatment regimens across four settings to demonstrate how UFMs can allow decision makers to adapt published results to their local context. We simplified a complex model to produce a UFM that provides similar results, the ability to modify key parameter values, and receive customized results in seconds

Original language	English
Pages (from-to)	257-260
Journal	International journal of tuberculosis and lung disease
Volume	20
Issue number	2
DOIs	https://doi.org/10.5588/ijtld.15.0415
Publication status	Published - 2016

Access to Document

https://doi.org/10.5588/ijtld.15.0415

Cite this

@article{1b75c87d1f4a4041b79ba73251bf0b3d,

title = "A simplified cost-effectiveness model to guide decision-making for shortened anti-tuberculosis treatment regimens",

abstract = "User-friendly models (UFMs) allow local decision makers to explore relationships and apply results from more detailed models of such outcomes as cost-effectiveness. When developing UFMs, modelers must decide which simplifications may be appropriate, enabling the UFM to retain accuracy while reducing complexity. We use the example of cost-effectiveness analysis (CEA) for novel shortened anti-tuberculosis treatment regimens across four settings to demonstrate how UFMs can allow decision makers to adapt published results to their local context. We simplified a complex model to produce a UFM that provides similar results, the ability to modify key parameter values, and receive customized results in seconds",

author = "A. Zwerling and Gomez, {G. B.} and J. Pennington and F. Cobelens and A. Vassall and Dowdy, {D. W.}",

year = "2016",

doi = "https://doi.org/10.5588/ijtld.15.0415",

language = "English",

volume = "20",

pages = "257--260",

journal = "International journal of tuberculosis and lung disease",

issn = "1027-3719",

publisher = "International Union against Tubercul. and Lung Dis.",

number = "2",

}

TY - JOUR

T1 - A simplified cost-effectiveness model to guide decision-making for shortened anti-tuberculosis treatment regimens

AU - Zwerling, A.

AU - Gomez, G. B.

AU - Pennington, J.

AU - Cobelens, F.

AU - Vassall, A.

AU - Dowdy, D. W.

PY - 2016

Y1 - 2016

N2 - User-friendly models (UFMs) allow local decision makers to explore relationships and apply results from more detailed models of such outcomes as cost-effectiveness. When developing UFMs, modelers must decide which simplifications may be appropriate, enabling the UFM to retain accuracy while reducing complexity. We use the example of cost-effectiveness analysis (CEA) for novel shortened anti-tuberculosis treatment regimens across four settings to demonstrate how UFMs can allow decision makers to adapt published results to their local context. We simplified a complex model to produce a UFM that provides similar results, the ability to modify key parameter values, and receive customized results in seconds

AB - User-friendly models (UFMs) allow local decision makers to explore relationships and apply results from more detailed models of such outcomes as cost-effectiveness. When developing UFMs, modelers must decide which simplifications may be appropriate, enabling the UFM to retain accuracy while reducing complexity. We use the example of cost-effectiveness analysis (CEA) for novel shortened anti-tuberculosis treatment regimens across four settings to demonstrate how UFMs can allow decision makers to adapt published results to their local context. We simplified a complex model to produce a UFM that provides similar results, the ability to modify key parameter values, and receive customized results in seconds

U2 - https://doi.org/10.5588/ijtld.15.0415

DO - https://doi.org/10.5588/ijtld.15.0415

M3 - Article

C2 - 26792481

SN - 1027-3719

VL - 20

SP - 257

EP - 260

JO - International journal of tuberculosis and lung disease

JF - International journal of tuberculosis and lung disease

IS - 2

ER -